Southport Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Southport Capital Management's AMGN Position: Q1 2022 in Review
Southport Capital Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 1,009 shares — an estimated $227K sold.
Southport Capital Management first reported a position in AMGN in Q2 2016 and held it in 18 quarters. The position peaked at $676K in Q3 2018. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- Southport Capital Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
- Southport Capital Management sold 1,009 Amgen shares in Q1 2022, an estimated $227K.
- Southport Capital Management first reported a position in Amgen in Q2 2016 and held it in 18 quarters.
- Southport Capital Management's Amgen position peaked at $676K in Q3 2018.
- 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.